Concepedia

Author

Wesley Lebel

Pfizer (United States)

Also Known As

W. S. Lebel, W.S. Lebel, Wesley Lebel, Wesley S. Lebel

14

Publications

1.2K

Citations

8

H-Index

23

Concepts

All Affiliations

Pfizer (United States)
WL

About

Wesley Lebel is an author at Pfizer (United States) specializing in medicine, physiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1K

2

Public Health

1

1

11

3

Anesthesia

1

1

60

4

Biochemistry

1

1

864

5

Endocrinology

1

1

11

Wesley Lebel

×

6

Publications

1.1K

Citations

6

H-Index

YearCitations

A Potent Nonpeptide Antagonist of the Substance P (NK <sub>1</sub> ) Receptor

R. Michael Snider, Jay W. Constantine, John Lowe,

Science

1991

864

Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets

David E. Johnson, Hanae Yamazaki, Karen Ward,

Diabetes

2005

129

Complete blockade by phenoxybenzamine of ?1- but not of ?2-vascular receptors in dogs and the effects of propranolol

Jay W. Constantine, Wesley Lebel

Naunyn-Schmiedeberg s Archives of Pharmacology

1980

60

Functional postsynaptic α2- but not α1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine

Jay W. Constantine, Wesley Lebel, Robert Archer

European Journal of Pharmacology

1982

56

Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors

Jay W. Constantine, Wesley Lebel, Heidi A. Woody,

European Journal of Pharmacology

1994

17

Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus

Ketti K. Terry, Wesley Lebel, Keith Riccardi,

Prostaglandins Leukotrienes and Essential Fatty Acids

2007

11

Page 1